SICA, Antonio
 Distribuzione geografica
Continente #
EU - Europa 6.749
NA - Nord America 6.456
AS - Asia 3.764
SA - Sud America 784
Continente sconosciuto - Info sul continente non disponibili 148
AF - Africa 102
OC - Oceania 12
Totale 18.015
Nazione #
US - Stati Uniti d'America 6.286
RU - Federazione Russa 1.529
IE - Irlanda 1.301
SG - Singapore 1.192
DE - Germania 918
CN - Cina 816
SE - Svezia 767
IT - Italia 717
HK - Hong Kong 629
BR - Brasile 595
UA - Ucraina 566
VN - Vietnam 513
FI - Finlandia 301
FR - Francia 233
GB - Regno Unito 127
IN - India 122
KR - Corea 109
BD - Bangladesh 95
EE - Estonia 86
CA - Canada 80
ID - Indonesia 75
AR - Argentina 73
MX - Messico 52
TR - Turchia 49
AT - Austria 42
ZA - Sudafrica 33
PL - Polonia 32
BE - Belgio 28
EC - Ecuador 28
IQ - Iraq 26
NL - Olanda 26
CO - Colombia 25
JP - Giappone 23
ES - Italia 22
BJ - Benin 19
PY - Paraguay 15
VE - Venezuela 15
EU - Europa 13
PK - Pakistan 13
AU - Australia 12
CL - Cile 12
MA - Marocco 11
PH - Filippine 11
SA - Arabia Saudita 11
TW - Taiwan 11
EG - Egitto 10
MY - Malesia 10
KZ - Kazakistan 9
PE - Perù 9
CZ - Repubblica Ceca 8
UY - Uruguay 8
UZ - Uzbekistan 8
CH - Svizzera 7
DZ - Algeria 7
JM - Giamaica 7
LT - Lituania 7
TN - Tunisia 7
DK - Danimarca 6
CR - Costa Rica 5
LB - Libano 5
NG - Nigeria 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
IR - Iran 4
JO - Giordania 4
PA - Panama 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
HN - Honduras 3
MT - Malta 3
NP - Nepal 3
RO - Romania 3
SC - Seychelles 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BG - Bulgaria 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
IL - Israele 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
OM - Oman 2
PR - Porto Rico 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GD - Grenada 1
GR - Grecia 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 17.873
Città #
Dublin 1.297
Jacksonville 964
Hong Kong 620
San Jose 501
Dearborn 466
Singapore 364
Chandler 353
Ashburn 352
Council Bluffs 331
Wilmington 238
Beijing 226
Moscow 202
Piemonte 195
Bremen 177
Lawrence 176
Princeton 176
Ho Chi Minh City 171
Los Angeles 164
Lauterbourg 160
San Mateo 146
Columbus 140
Ann Arbor 118
Andover 113
Hanoi 95
Seoul 93
Buffalo 90
Santa Clara 84
New York 68
São Paulo 59
Düsseldorf 57
Orem 55
Milan 53
Dallas 47
Novara 47
Boardman 45
Munich 44
Houston 43
Phoenix 37
Guangzhou 36
Woodbridge 36
Frankfurt am Main 34
Dong Ket 32
Nuremberg 32
Hefei 31
Jakarta 31
Redondo Beach 31
Philadelphia 29
Brooklyn 27
Nanjing 27
Da Nang 26
Atlanta 25
Haiphong 24
Norwalk 24
Tianjin 24
Chennai 23
Hangzhou 22
Helsinki 22
Warsaw 22
Tokyo 21
Brussels 20
Mexico City 20
Montreal 20
Shanghai 20
Cotonou 19
Toronto 19
Poplar 18
Denver 17
Turin 17
London 16
Rio de Janeiro 16
Vienna 16
Stockholm 15
Amsterdam 14
Boston 14
Kunming 14
Mumbai 14
Charlotte 13
Chicago 13
Johannesburg 13
Dhaka 12
Fairfield 11
Guayaquil 11
Hải Dương 11
New Delhi 11
Porto Alegre 11
Rome 11
Asunción 10
Brasília 10
Falkenstein 10
Manchester 10
Ninh Bình 10
San Francisco 10
Baghdad 9
Biên Hòa 9
Casalecchio Di Reno 9
Kocaeli 9
Manaus 9
Naples 8
Nichelino 8
Recife 8
Totale 9.681
Nome #
Cancer immunity and immunotherapy beyond COVID-19 250
Nicotinamide Phosphoribosyltransferase (NAMPT) acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 182
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection 181
Heme catabolism by tumor-associated macrophages controls metastasis formation 178
The p50 NF-κB subunit is a prognostic regulator of colorectal cancer-associated inflammation 173
Inflammaging and Osteoarthritis. 167
Macrophage polarization in pathology 160
(0) Save to: more options FUNCTIONAL INTERACTION OF NF-KAPPA-B WITH INTERFERON-GAMMA GENOMIC DNA - IDENTIFICATION OF MULTIPLE NF-KAPPA-B AND NF-AT BINDING-SITES 156
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies 151
RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis 150
Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC. 149
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors: novel modulators of antitumor immunity 145
Pro-tumor steering of cancer inflammation by p50 NF-κB enhances colorectal cancer progression 140
Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis 140
Functions of diverse myeloid cells in the tumor micro-environment 139
The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance 138
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 136
Molecular and epigenetic basis of macrophage polarized activation 134
Bacterial lipopolisaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes 131
Metabolic influence on the differentiation of suppressive myeloid cells in cancer. 131
A distinct and unique transcriptional programme expressed by tumor-associated macrophages: defective NF-{kappa}B and enhanced IRF-3/STAT1 activation 130
A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. 129
Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy 129
Hypoxia-mediated regulation of macrophage functions in pathophysiology 128
Immunometabolic interference between cancer and COVID-19 126
Cancer-related Inflammation 125
Metabolic regulation of suppressive myeloid cells in cancer 125
Hypoxia-mediated regulation of macrophage functions in pathophysiology. 124
Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and non-hematopoietic cells 122
A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). 122
Myeloid-derived suppressor cells: Ductile targets in disease 122
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages 122
The role of cytokines as communication signals between leukocytes and endothelial cells. 121
AIRE modulates IFN- expression in T lymphocytes 121
Macrophage polarization in tumour progression 121
RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression 119
LPS-tolerant monocytes/macrophages express a distinct M2 functional profile 118
A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization 118
A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. 116
Activation of nuclear factor of activated T cells in a cyclosporin A-resistant pathway. 114
Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. 114
Interleukin-6 gene expression and production induced in human monocytes by membrane proteoglycans from Klebsiella pneumoniae. 113
IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member in Trypanosoma congolense infection-resistant C57BL/6 mice 113
Cellular and molecular pathways linking inflammation and cancer 112
Interaction of NF-kB and NFAT with the Interferon-gamma Promoter 111
Influence of innate immunity on cancer cell stemness 111
Targeting cancer cells and tumor microenvironment in preclinical and clinical models of Hodgkin lymphoma using the dual PI3Kd/G inhibitor RP6530 109
Inflammation as target in cancer therapy 108
ALTERATIONS IN NF-KAPPA-B/REL FAMILY PROTEINS IN SPLENIC T-CELLS FROM TUMOR-BEARING MICE AND REVERSAL FOLLOWING THERAPY 108
Lipid metabolism and cancer immunotherapy: Immunosuppressive myeloid cells at the crossroad 107
Oncolytic virotherapy: new weapon for breast cancer treatment 107
Inflammation and cancer: breast cancer as a prototype 106
Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. 106
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors are novel modulators of myeloid-derived suppressor cells 105
Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective. 104
Autocrine production of interleukin-10 (IL-10) mediates defective IL-12 production and NF-kappa B activation in tumor associated macrophages 104
Endothelial cells express the interleukin-1 receptor type I. 103
NF-kappa B p50 regulates mast cell survival in part through upregulation of miR-146a 103
The p50 subunit of NF-?B orchestrates dendritic cell lifespan and activation of adaptive immunity. 103
Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel. 102
convergent pathways of macrophage polarization: the role of B cells 102
Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases 102
Precision Medicine Approaches with Metabolomics and Artificial Intelligence 101
IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. 101
GADD45β loss ablates innate immunosuppression in cancer 101
High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. 100
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene 100
Altered macrophage differentiation and immune dysfunctions during tumor development 100
Heme catabolism and heme oxygenase-1-expressing myeloid cells in pathophysiology 98
MiR-146a and NF-kB1 regulate mast cell survival and T lymphocyte differentiation 98
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out 98
SPARC is a new myeloid-derived suppressor cell marker licensing suppressive activities 98
Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema. 97
Cancer related inflammation: the macrophage connection. 96
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. 96
Autocrine production of Interleukin-10 (IL-10) mediates defective IL-12 production and NF-kB activation in Tumor Associated Macrophages 96
Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target. 96
NF-KAPPA-B AND A P120 INTERACT WITH THE IFN-GAMMA INTRONIC CREL BINDING-SITE C3 95
Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. 95
Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation. 95
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. 95
Nicotinamide Phosphorybosyltransferase (NAMPT) Inhibitors are Novel Modulator of Cancer-Related Inflammation 95
Expression of c-jun protooncogene in human myelomonocytic cells. 94
Macrophage activation and polarization. 93
Frailty in Rheumatic Diseases 93
Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. 92
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy. 92
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors 92
Immunometabolic status of covid-19 cancer patients 92
Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. 91
MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression. 91
Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs) 91
Defective expressione of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma 90
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. 90
Linking inflammation reactions to cancer: novel targets for therapeutic strategies. 90
Suppressors of cytokine signalling (SOCS) 2 and 3 diametrically control macrophage polarisation 90
Macrophage activation and polarization as an adaptive component of innate immunity 90
Implications of metabolism-driven myeloid dysfunctions in cancer therapy 90
IDENTIFICATION OF NOVEL PROTEIN-BINDING SEQUENCES IN THE 1ST INTRON OF HUMAN INTERFERON-GAMMA-GENOMIC DNA 89
Share Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer. 88
Totale 11.525
Categoria #
all - tutte 89.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.235 0 0 271 200 47 20 129 16 88 19 180 265
2022/20232.775 199 114 121 103 331 244 42 173 1.321 8 77 42
2023/2024757 56 48 74 22 134 16 201 27 4 9 40 126
2024/20252.293 54 12 123 72 50 97 190 247 572 339 148 389
2025/20266.154 201 229 569 1.078 526 436 736 992 450 450 325 162
2026/2027957 261 560 136 0 0 0 0 0 0 0 0 0
Totale 18.015